Skip to content
Recall Observatory FDA recall evidence

Device product

DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum

Z-0779-2017

November 16, 2016

Class III

Product summary

Firm
PerkinElmer Health Sciences, Inc.
Event
Event 75708
Status
Terminated
Classification
Class III
Quantity
79 kits
Official record key
device-enforcement:Z-0779-2017

Official wording

Reason: A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76  67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.

Code information: Lot Number: 646091

Distribution pattern: CA, CO, NY, WA Foreign: Austria, Bolivia, Bosnia , Sweden, Norway, Netherlands, Japan, Great Britain,

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76  67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.